The agency said that a booster could be administered at least six months after severely or moderately immunocompromised adults received a third dose of an mRNA vaccine that was authorized over the summer just for them.
Published: October 28, 2021 at 01:21AM
from NYT Health https://ift.tt/2Zu8599